MassBio leadership team visits Cummings’ life sciences clusters


WOBURN, Mass. – Members of the leadership team of Massachusetts Biotechnology Council (MassBio) recently visited Cummings Center and Dunham Ridge in Beverly and Cummings Properties’ flagship TradeCenter 128 campus in Woburn to tour several life sciences companies.

The visits focused on MassBio’s vision for the future of the biotech industry and showcased innovations happening in the MetroNorth communities.

A not-for-profit organization that represents and provides services and support for the Massachusetts life sciences industry, MassBio is the nation’s oldest biotechnology trade association. It was founded in 1985 and has more than 1,500 members. Based in Cambridge, MassBio maintains a satellite office at Cummings Center.

“MassBio plays an important role in supporting biotech growth in Massachusetts,” said Eric Anderson, president of Cummings Properties. “We were pleased to have the opportunity to highlight for its leadership just a handful of the many companies that are driving innovation in the MetroNorth life sciences clusters.”

Joe Boncore, MassBio’s CEO, and Kendalle Burlin O’Connell, Esq., president and chief operating officer, participated in a fireside chat in Beverly. The discussion was moderated by Tracy Curley, chief financial officer of iSpecimen and president of North Shore Technology Council, which hosted the event.

The visiting contingent, which included Senator Joan Lovely and Representative Jerald Parisella, toured Cummings Center firms North Shore InnoVentures and LexaGene, as well as Dunham Ridge firms Adept Therapeutics, Resolute Bio, and Endolytix.

In Woburn, Boncore and his team’s visit involved facilities tours with Cambridge Polymer Group, SpearBio, Rgenta Therapeutics, and Batavia Biosciences. Representatives from Hopewell Therapeutics, SeromYx, and Vaxess Technologies joined the group for the follow-on reception at Strega Italiano.

Woburn and Beverly are home to approximately 100 and 60 biotech firms, respectively, according to Anderson.

“Cummings’ ability to quickly design, build, and manage first-class lab space, along with our favorable lease rates and an already thriving hub of industry activity, make Beverly and Woburn ideal locations for life sciences businesses,” said Anderson.

Both Beverly and Woburn, along with most of the cities and towns where Cummings operates, have earned MassBio’s Platinum Level Bioready® Community rating. This designation signifies the communities’ commitment to the life sciences industry through streamlined permitting, robust infrastructure, and pre-permitted biotech sites.